日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer and COVID-19: A review of immune insights and partnerships to inform public health strategy

癌症与新冠肺炎:免疫学见解与合作综述,为公共卫生策略提供信息

Hempel, Heidi; Xue, Huijing; La Shu, Shin; Jain, Shweta; Kemp, Troy J; Pinto, Ligia A

Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccination

开发HPV 35血清学检测方法,用于评估感染和接种疫苗后对HPV 35的免疫反应。

Kim, Kathleen; Porras, Carolina; Kreimer, Aimee R; Hempel, Heidi; Kemp, Troy J; Lowy, Douglas R; Pinto, Ligia A

Development and calibration of an HPV serology secondary standard for measuring antibody responses in HPV vaccine trials: a preliminary report

HPV疫苗试验中用于测量抗体反应的HPV血清学二级标准的开发和校准:初步报告

Kemp, Troy J; Wilkinson, Dianna E; Panicker, Gitika; Eklund, Carina; Miller, Cheryl; Dillner, Joakim; Beddows, Simon; Unger, Elizabeth R; Pinto, Ligia A

Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial

在多里森试验中,坦桑尼亚女孩接种一剂和两剂加卫苗®9的免疫原性

Kemp, Troy J; Baisley, Kathy; Changalucha, John; Indangasi, Jackton; Whitworth, Hilary; Lacey, Charles J; Mwanzalima, David; Hashim, Ramadhan; Kapiga, Saidi; Hayes, Richard J; Pinto, Ligia A; Watson-Jones, Deborah

Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters

癌症患者多次接种新冠疫苗加强针后体内循环的SARS-CoV-2刺突蛋白IgG抗体反应

Xue, Huijing; Kemp, Troy J; North, Hayley; Roche, Nancy V; Hickey, Thomas E; Pinto, Ligia A

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions

2019冠状病毒病(COVID-19)真实世界数据基础设施:用于研究COVID-19对免疫功能低下患者群体影响的大数据资源

Crawford, James M; Penberthy, Lynne; Pinto, Ligia A; Althoff, Keri N; Assimon, Magdalene M; Cohen, Oren; Gillim, Laura; Hammonds, Tracy L; Kapur, Shilpa; Kaufman, Harvey W; Kwasny, David; Liew, Jean W; Meyer, William A 3rd; Reynolds, Shannon L; Schleicher, Cheryl B; Subbiah, Suki; Theruviparampil, Catherine; Wallace, Zachary S; Warner, Jeremy L; Yoon, Suhyeon; Ziemba, Yonah C

Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment

癌症患者接受治疗后接种第二剂新冠病毒mRNA疫苗的体液免疫反应

Dang, Christine M; Kemp, Troy J; Roche, Nancy; Haynesworth, Katarzyna; Loftus, Sarah A; Borski, Benjamin J; El Bakouny, Ziad; Labaki, Chris; Lee, Gwo-Shou Mary; Trowbridge, Rachel; Strauss, Sarah; Hughes, Melissa E; Lin, Nancy U; Choueiri, Toni K; Pinto, Ligia A

Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment

接受积极治疗的癌症患者群体对 COVID-19 mRNA 疫苗初次免疫接种后的中和抗体反应

Xue, Huijing; Kemp, Troy J; Li, Chenglei; Roche, Nancy V; Bakouny, Ziad; Labaki, Chris; Lee, Guo-Shou Mary; Trowbridge, Rachel; Strauss, Sarah; Hughes, Melissa E; Lin, Nancy U; Choueiri, Toni K; Pinto, Ligia A

Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice.

在小鼠中,将合成的 TLR4 激动剂与 RG1-VLP 疫苗结合使用,可以实现免疫谱多样性

Matthews Rebecca L, Khan Nazneen, Beckman Bradley, Sharma Simran, Dietz Zackary, Picking William D, Izmirlian Grant, Sanders Chelsea, Stocks Stacy M, Difilippantonio Simone, Kirnbauer Reinhard, Roden Richard B, Pinto Ligia A, Shoemaker Robert H, Ernst Robert K, Marshall Jason D

Evaluation of Anti-HPV18 Antibody Titers Preceding an Incident Cervical HPV18/45 Infection

评估宫颈HPV18/45感染发生前抗HPV18抗体滴度

Wiek, Fanua; Shankar, Viswanathan; Gradissimo, Ana; Diaz, Angela; Pinto, Ligia A; Schlecht, Nicolas F; Burk, Robert D